Patents by Inventor Bart Henderson

Bart Henderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Treating Melanocortin-4 Receptor-Associated Disorders in Heterozygous Carriers
    Publication number: 20140329743
    Abstract: A method of treating a disorder in a subject. The method comprises administering to said subject an effective amount of an agonist of the melanocortin-4 receptor (MC4R). The subject is a heterozygous carrier of an MC4R mutation, and the disorder results from an attenuated response of MC4R to a-melanocortin stimulating hormone (a-MSH).
    Type: Application
    Filed: December 28, 2012
    Publication date: November 6, 2014
    Inventors: Louis A. Tartaglia, Bart Henderson
  • Method of drug delivery for bone anabolic protein
    Patent number: 8748382
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: June 10, 2014
    Assignees: Radius Health, Inc., Ipsen Pharma S.A.S.
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle
  • METHOD OF DRUG DELIVERY FOR BONE ANABOLIC PROTEIN
    Publication number: 20130157955
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Application
    Filed: April 3, 2012
    Publication date: June 20, 2013
    Applicants: Ipsen Pharma S.A.S., Radius Health, Inc.
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle
  • Stable composition comprising a PTHrP analogue
    Patent number: 8148333
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) analogue and methods of using a PTHrP analogue and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Grant
    Filed: October 3, 2007
    Date of Patent: April 3, 2012
    Assignees: Radius Health, Inc., Ipsen Pharma S.A.S.
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle
  • METHOD OF DRUG DELIVERY FOR BONE ANABOLIC PROTEIN
    Publication number: 20110092425
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Application
    Filed: August 12, 2010
    Publication date: April 21, 2011
    Applicants: Radius Health, Inc., Ipsen Pharma S.A.S
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle
  • Method of treating osteoporosis comprising administration of PTHrP analog
    Patent number: 7803770
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Grant
    Filed: May 9, 2008
    Date of Patent: September 28, 2010
    Assignees: Radius Health, Inc., Ipsen Pharma S.A.S.
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle
  • Treatment of vasomotor symptoms with selective estrogen receptor modulators
    Publication number: 20100105733
    Abstract: The present invention is directed toward methods for treating vasomotor symptoms, (e.g., hot flashes and night sweats) in a patient in need thereof comprising administering a SERM as described herein.
    Type: Application
    Filed: June 22, 2007
    Publication date: April 29, 2010
    Inventors: C. Richard Lyttle, Bart Henderson, Gary Hattersley
  • Stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof
    Publication number: 20100029556
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) analogue and methods of using a PTHrP analogue and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Application
    Filed: October 3, 2007
    Publication date: February 4, 2010
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle
  • Method of drug delivery for bone anabolic protein
    Publication number: 20090227498
    Abstract: The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
    Type: Application
    Filed: May 9, 2008
    Publication date: September 10, 2009
    Applicant: Radius Health, Inc.
    Inventors: Michael J. Dey, Nathalie Mondoly, Benedicte Rigaud, Bart Henderson, C. Richard Lyttle